The expanding demand for specific immunological investigation and therapeutic development has spurred significant advances in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using diverse expression systems, including microbial hosts, higher cell populations, and